Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients
Abstract Background Coronavirus disease 2019 (COVID-19) causing severe acute respiratory distress syndrome caused by coronavirus 2 (SARS-CoV-2) still has no solid effective therapy. From previous studies, dexamethasone has led to a decrease in mortality in patients who required oxygen supplementatio...
Shranjeno v:
Main Authors: | , , |
---|---|
Format: | Knjiga |
Izdano: |
SpringerOpen,
2022-02-01T00:00:00Z.
|
Teme: | |
Online dostop: | Connect to this object online. |
Oznake: |
Označite
Brez oznak, prvi označite!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Kopija 1 | Prosto |